Annie discusses the evolution of Oak HCFT, emphasizing their focus on technology-enabled solutions in healthcare rather than traditional life sciences investments. The conversation highlights the resurgence of life sciences since 2010, driven by innovations like CRISPR, and the significant overlap between healthcare and fintech, where regulatory challenges create unique investment opportunities.
